Skip to content

Effect of neucleoplasty in management of prolapsed intervertebral disc disease

Role of Nucleoplasty for management of painful contained herniated disc: A study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018159
Enrollment
30
Registered
2019-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: Neucleoplasty: After positive discography result, patient will undergo the neuclaplasty procedure under aseptic condition and fluoroscopic guidance with proper antibiotic coverage. The

Sponsors

ESI Institute of Pain Management
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. Symptomatic prolapsed intervertebral disc disease with VAS score more than 7 after walking or standing for 15 minutes. 3. Already treated for 3 months with antineuropathic medicines without satisfactory improvement, failed conservative therapy. 4. In MRI there is prolapsed intervertebral disc & disc height is maintained (more than 50%). 5. Patients who did not want open neurosurgery and give consent for nucleoplasty and minimal disk intervention.

Exclusion criteria

Exclusion criteria: 1. Patients with motor deficit or significant sensory loss or bladder bowel involvement. 2. Cauda equina syndrome 3. Severe spinal canal stenosis 4. Loss of disk height > 50%. 5. Spinal fracture or tumor 6. Patients who want neurosurgery. 7. Coagulopathy 8. Local skin infection

Design outcomes

Primary

MeasureTime frame
Pain in NRS scoreTimepoint: before Neucleoplasty and after 2 weeks, 3 months & 6 months after procedure

Secondary

MeasureTime frame
functional disability in Ronald Morris Disability Questionnaire ScoreTimepoint: before Neucleoplasty and after 2 weeks, 3 months & 6 months after procedure

Countries

India

Contacts

Public ContactSubrata Goswami

ESI Institute of Pain Management

drsgoswami@gmail.com9830430430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026